Clearer Skin Starts Here Trio | The INKEY List

Meet the Clearer Skin Starts Here set, a powerhouse trio of fast-acting skincare, specially formulated to help support you at every stage of your blemish journey, from blemishes and blackheads to post-breakout dark spots. These products form the base of your essential blemish-prone skin routine, working together to help unclog pores, minimize excess oil, and reduce the appearance of blemishes and redness. With continued use, this set leaves you with clearer-looking, more balanced skin.              ​

CLEANSE – Salicylic Acid Cleanser:​ The ultimate oil-reducing and blemish-busting cleanser for a visibly clearer complexion in 3 days*. Hero ingredient 2% Salicylic Acid (BHA) works within pores to help unclog and gently exfoliate, helping to visibly reduce blackheads and breakouts. ​

TREAT – Succinic Acid Treatment: Suitable for surface level red blemishes without a visible head, this targeted, non-drying treatment helps to visibly reduce active blemishes and the appearance of redness in 12 hours**. The combination of Succinic Acid and Salicylic Acid boosts the natural skin exfoliation process to help decongest pores, visibly reduce redness, and improve post-blemish dark spots whilst remaining gentle on the skin. For breakouts with a head and visible gunk, try the deluxe sample of Hydrocolloid Invisible Pimple Patches. Clinically proven to visibly reduce breakouts in just 4 hours***, these ultra-fine, ultra-matte and undetectable patches help to cover up and visibly clear breakouts at rapid speed.​

MOISTURIZE – Omega Water Cream: The ultimate quencher for thirsty skin, this oil-free moisturizer delivers a lightweight drench of hydration for plump, dewy skin. Suitable for all skin types, including oily and blemish-prone it is formulated with a skin-supporting combination of Niacinamide to help visibly minimize excess oil and even skin tone and Omega Fatty Acids and Glycerin to help lock in hydration.​

* 4-week independent consumer trial of 66 people ​

** 4-week independent consumer trial of 22 people​

***Clinical study of 20 people